About

Redefining Inflammation Through Precision Modulation of the IL‑6/gp130 Axis

Innata Bio is pioneering a new class of anti‑inflammatory medicines built on a simple but powerful idea: inflammation shouldn’t be turned off — it should be precisely controlled.

Where today’s therapies act like binary switches, shutting down entire pathways, Innata’s small molecule modulators fine‑tune the IL‑6/gp130 axis to reduce harmful inflammation while preserving the regenerative and homeostatic signals the body uses to deploy the immune system to heal.

This is inflammation redefined — precision over suppression, tuning over blocking, biology restored rather than silenced.

Leadership

Our team and technology are revolutionizing medical science.

Headshot of Hassan Serhan, PhD a man with glasses and beard smiling straight on.
Hassan Serhan, PhD
Innata Bio CEO
Headshot of Hassan Serhan, PhD a man with glasses and beard smiling straight on.

Hassan Serhan, PhD is a seasoned healthcare leader with deep expertise in technology innovation, product development, and leading large-scale global programs.

He held senior leadership roles and served as a Distinguished Fellow at Johnson & Johnson’s DePuy Synthes.

Headshot of Ben Van Handel, PhD a man with short hair in a suit jacket.
Ben Van Handel, PhD
Innata Bio Co-founder & CSO
Headshot of Ben Van Handel, PhD a man with short hair in a suit jacket.

Ben Van Handel, PhD is an accomplished stem cell scientist, award-winning researcher, and experienced entrepreneur with a proven track record of bringing innovative therapies to market.

He holds a BS in Biochemistry from Northern Michigan University (summa cum laude) and a PhD in Molecular, Cell, and Developmental Biology from UCLA.

Headshot of Ron Ellis DO, MBA a man with short hair in a suit jacket smiling.
Ron Ellis, DO, MBA
Strategic Advisor
Headshot of Ron Ellis DO, MBA a man with short hair in a suit jacket smiling.

Ron Ellis, DO, MBA worked for a number of years at global banks, such as Citigroup and Deutsche Bank, as well as the healthcare boutique, Leerink Partners. For nearly a decade, Ron led Business Development at Pacira BioSciences with responsibility for strategy, partnering, acquisitions, competitive intelligence and new product planning for its acute post-surgical and chronic musculoskeletal pain management franchises.

Ron received his BS in Biology and his MBA (summa cum laude) from St. Joseph’s University and then went on to earn his DO at the Philadelphia College of Osteopathic Medicine.

Headshot of Greg Sieczkiewicz, PhD, JD a man with short hair smiling.
Greg Sieczkiewicz, PhD, JD
Strategic Advisor Biotech Patent Strategy
Headshot of Greg Sieczkiewicz, PhD, JD a man with short hair smiling.

Greg Sieczkiewicz, PhD, JD has been the IP strategy architect for more than a dozen venture-backed life sciences companies. He has served as Chief IP Counsel at MPM Bioimpact, Vice President, IP at Flagship Ventures and also practiced patent counseling and enforcement at national law firms Mintz Levin, Proskauer Rose and Foley Hoag.

He received his J.D., magna cum laude, from the evening program of Suffolk University Law School and earned his Ph.D. in Cell, Molecular and Developmental Biology from Tufts University School of Medicine.

Scientific & Clinical Advisory Board

Our advisory board features scientific experts that lead research in their respective fields.

Osteoarthritis

Headshot of Nancy Lane, MD a woman with short curly hair smiling.

Nancy E. Lane, MD

Dr. Lane is an Endowed and Distinguished Professor of Medicine, Rheumatology and Aging Research as well as the Director for the Center for Musculoskeletal Health at the University of California at Davis School of Medicine. She is currently the president-elect of the Osteoarthritis Research Society International (OARSI).

Pulmonary Fibrosis

Headshot of Toby Maher, MD a man with short hair smiling.

Toby Maher, MD, PhD

Dr. Maher is a Professor of Clinical Medicine and Director of interstitial lung disease (ILD) at Keck School of Medicine of University of Southern California as well as formerly an Honorary Professor of ILD at Imperial College, London and the British Lung Foundation Chair.

Cardiometabolic

Headshot of Mazen Noureddin, MD, MHSc a man wearing glasses with a close cut beard and mustache and short hair smiling.

Mazen Noureddin, MD, MHSc

Dr. Noureddin is an internationally recognized hepatologist and a leading authority in fatty liver disease (NAFLD/NASH). Founder and Medical Director of the Houston Liver Institute and Houston Research Institute, former director of the Fatty Liver Program at Cedars-Sinai Medical Center in Los Angeles.